1,206
Views
15
CrossRef citations to date
0
Altmetric
OriginalArticle

DNA repair genes polymorphisms in multiple myeloma: no association with XRCC1 (Arg399Gln) polymorphism, but the XRCC4 (VNTR in intron 3 and G-1394T) and XPD (Lys751Gln) polymorphisms is associated with the disease in Turkish patients

, , , , &
Pages 361-367 | Published online: 12 Nov 2013

References

  • Kyle RA, Rajkumar SV. Multiple myeloma. NEngl J Med 2004;351:1860–73.
  • Rajkumar SV, Kyle RA. Plasma cell disorders. In: , Goldman L, Ausiello D, editors. Cecil textbook of medicine. 23rded. Philadelphia, PA: Saunders; 2007.p. 1426–37.
  • Shimizu Y, Kato H, Schull WJ. Studies of the mortality of A-bomb survivors.9. Mortality, 1950–1985: Part 2. Cancer mortality based on the recentlyrevised doses (DS86). Radiat Res 1990;121:120–41.
  • Fonscca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M, et al.. Genetics and cytogenetics of multiplmyeloma: a workshop report. Cancer Res 2004;64:1546–58.
  • Fenton JA, Pratt G, Rawstron AC, Morgan GJ. Isotype class switching and pathogenesis ofmultiple myelome. Hematol Oncol 2002;20:75–85.
  • Bohr VA. DNA repair fine structure and its relationsto genomic instability. Carcinogenesis 1995;16:2885–92.
  • Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei DD, Groshen S, Lenz HJ. A Xeroderma pigmentosum group D gene polymorphismpredicts clinical outcome to platinum based chemotherapy in patients withadvanced colorectal cancer. Cancer Res 2001;61:8654–8.
  • De Boer J, Hoeijmakers J. Nucleotide excision repair and human syndromes. Carcinogenesis 2000;21:453–60.
  • Caldecott KW, Aoufouchi S, Shall S. XRCC1 polypeptide interacts with DNA polymeraseand possibly poly (ADP-riboz) polymerase, and DNA Ligase III is a novel molecular ‘nicksensor’ in vitro. Nucleic Acid Res 1996;24:4387–97.
  • Hayden PJ, Tewari P, Morris WD, Staines A, Crowley D, Nieters A, et al.. Variation in NA repair genes XRCC3,XRCC4, XRCC5 and susceptibility to myeloma. Hum MolGenet 2007;16:3117–27.
  • Sreeja L, Syamala VS, Syamala V, Hariharan S, Raveendran PB, Vijayalekshmi RV, et al.. Prognostic importance of DNA repairgene olymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patientsfrom India. J Cancer Res Clin Oncol 2008;134:645–52.
  • Chiu CF, Tsai MH, Tseng HC, Wang CL, Wang CH, Wu CN, et al.. A novel single nucleotide polymorphismin XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. OralOncol 2008;44:898–902.
  • http://ihg2.helmholtz-muenchen.de/cgi-bin/hw/hwa1.pl
  • Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. JAm Stat Assoc 1958;53:457–81.
  • Cox DR. Regression models and life tables. JR Stat Soc (B) 1972;34:187.
  • Durie BGM, Harousseau J-L, Miguel JS, Bladé J, Barlogie B, Anderson K, et al.. International uniform response criteriafor multiple myeloma. Leukemia 2006;20:1467–73.
  • Hung RJ, Hall J, Brennan P, Boffetta P. Genetic polymorphisms in the base excisionrepair pathway and cancer risk: a HuGE review. AmJ Epidemiol 2005;126:925–42.
  • Rudd MF, Sellick GS, Webb EL, Catovsky D, Houlston RS. Variants in the ATM-BRCA2-CHEK2 axis predisposeto chronic lymphocytic leukemia. Blood 2006;108:638–44.
  • Chen S, Tang D, Xue K, Xu L, Ma G, Hsu Y, et al.. DNA repair gene XRCC1 and XPD polymorphismsand risk of lung cancer in a Chinese population. Carcinogenesis 2002;23:1321–5.
  • Allan JM, Smith AG, Wheatley K, Hills RK, Travis LB, Hill DA, et al.. Genetic variation in XPD predicts treatmentoutcome and risk of acute myeloid leukemia following chemotherapy. Blood 2004;104:3872–7.
  • Mehta PA, Alonzo TA, Gerbing RB, Elliott JS, Wilke TA, Kennedy RJ, et al.. Children’s Oncology Group. XPDLys751Gln polymorphism in the etiology and outcome of childhood acute myeloidleukemia: a Children’s Oncology Group report. Blood 2006;107:39–45.
  • Smedby KE, Lindgren CM, Hjalgrim H, Humphreys K, Schöllkopf C, Chang ET, et al.. Variation in DNA repair genes ERCC2,XRCC1 and XRCC3 and risk of follicular lymphoma. CancerEpidemiol Biomarkers Prev 2006;15:258–65.
  • Joseph T, Kusumakumary P, Chacko P, Abraham A, Pillai MR. DNA repair gene XRCC1 polymorphisms in childhoodacute lymphoblastic leukemia. Cancer Lett 2005;217:17–24.
  • Hill DA, Wang SS, Cerhan JR, Davis S, Davis S, Cozen W, et al.. Risk of non-Hodgkin lymphoma (NHL)in relation to germline variation in DNA repair and related genes. Blood 2006;108:3161–7.
  • Shen M, Purdue MP, Kricker A, Lan Q, Grulich AE, Vajdic CM, et al.. Polymorphisms in DNA repair genes andrisk of non-Hodgkin lymphoma in New South Wales, Australia. Haematologica 2007;92:1180–5.
  • Matsuo K, Hamajima N, Suzuki R, Andoh M, Nakamura S, Seto M, et al.. Lack of association between DNA baseexcision repair gene XRCC1 Gln399Arg polymorphism and risk of malignant lymphomain Japan. Cancer Genet Cytogenet 2004;140:77–80.
  • Chiu CF, Wang CH, Wang CL, Lin CC, Hsu NY, Weng JR, et al.. A novel single nucleotide polymorphismin XRCC4 gene is associated with gastric cancer susceptibility in Taiwan. AnnSurg Oncol 2008;15:514–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.